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bstract
Rapid uterine involution in the postpartum period of dairy cows is important to achieve a short interval to conception. Expression
atterns for members of the insulin-like growth factor (IGF) family were determined by in situ hybridisation at day 14 ± 0.4
ostpartum (n = 12 cows) to investigate a potential role for IGFs in modulating uterine involution. Expression in each uterine tissue
egion was measured as optical density units and data were analysed according to region and horn. IGF-I mRNA was localized to
he sub-epithelial stroma (SES) of inter-caruncular and caruncular endometrium. Both IGF-II and IGF-1R expression was detected
n the deep endometrial stroma (DES), the caruncular stroma and myometrium. IGFBP-2, IGFBP-4 and IGFBP-6 mRNAs were all
ocalised to the SES of inter-caruncular and caruncular uterine tissue, and in the DES and caruncular stroma, with IGFBP-4 mRNA
dditionally expressed in myometrium. IGFBP-3 mRNA was only detectable in luminal epithelium. IGFBP-5 mRNA was found
n myometrium, inter-caruncular and caruncular SES and caruncular stroma. These data support a role for IGF-I and IGF-II in the
xtensive tissue remodelling and repair which the postpartum uterus undergoes to return to its non-pregnant state. The differential
xpression of binding proteins between tissues (IGFBP-3 in epithelium, IGFBP-2, -4, -5 and -6 in stroma and IGFBP-4 and -5 in
yometrium) suggest tight control of IGF activity within each compartment. Differential expression of many members of the IGF
amily between the significantly larger previously gravid horn and the previously non-gravid horn may relate to differences in their
ate of tissue remodelling.
2007 Elsevier Inc. Open access under CC BY license.eywords: Bovine; Uterus; IGF; IGFBP; Involution
. IntroductionIn dairy cows, the peri-partum period is critical to
uture milk production and fertility. Uterine involu-
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Open access under CC BY license.tion involves extensive restructuring of the extracellular
matrix alongside mitogenesis and apoptosis [1–3]. Ini-
tial degeneration of placental cotyledons and maternal
caruncles accumulate as tissue debris in the uterine
lumen forming a lochial discharge [4]. Contractions of
the myometrium aid expulsion of lochia, and also restore
uterine size, shape and tone to that of a non-pregnant ani-
mal [5,6]. Whilst most of these changes have occurred
within 2–3 weeks postpartum, involution is not con-
sidered complete until about 40–50 days postpartum
imal En392 S. Llewellyn et al. / Domestic An
[1]. The previously non-gravid uterine horn returns to
a non-pregnant state 10–15 days earlier than the previ-
ously gravid uterine horn [7]. Histological repair of the
endometrium lags physical involution by 10–20 days
[8], completing when caruncles regenerate epithelium
[4]. Microbial contamination of the postpartum uterus is
almost universal during the first week postpartum [9].
When pathogenic bacteria are not cleared the uterus
becomes infected and inflamed and uterine involution is
delayed [1,10]. Clinical endometritis is characterised by
the continued presence of a purulent discharge beyond
21 days after calving [1].
Many processes involved in uterine repair are com-
mon to those of wound healing in other tissues (for a
review see [11]). Potential mediators of tissue turnover
and remodelling in the uterus include cytokines, matrix-
degrading enzymes and growth factors [11,12]. The
insulin-like growth factors (IGF-I and IGF-II) func-
tion in such tissue repair processes. In healing-impaired
wounds, the mRNA for IGF-I, IGF-1R, and IGFBP-3 is
significantly reduced [13]. The administration of IGF-
I to these wounds corrects defective tissue repair [14]
and in combination with other growth factors it increases
connective tissue regeneration and epithelialisation [15].
Components of the IGF system have been described in
the uteri of a variety of species (e.g. humans [16], rodents
[17], pigs [18], cattle [19], and sheep [20]). The pro-
liferative and differentiating effects of IGFs on uterine
cells are thought to support the growth and regression of
uterine tissue throughout the estrous cycle and also the
regenerative processes in women following menstrua-
tion [16,21]. IGFBP-2 has also been shown to stimulate
endometrial cell mitogenesis directly [22].
An increased rate of uterine involution is associated
with earlier resumption of ovarian activity [23], which
is in turn important for increasing pregnancy rate to first
service [24]. Conversely, endometrial damage associated
with sub-clinical endometritis leads to prolonged inter-
vals to conception, with many cows failing to conceive
at all [25]. The mechanisms that regulate uterine invo-
lution are not completely understood and, to the best of
our knowledge, no previous studies have investigated the
uterine IGF system during involution in lactating dairy
cows. We postulated that changes in IGF bioavailabil-
ity may be implicated in the rate of postpartum uterine
recovery and thus influence the calving to conception
interval and reproductive efficiency. The objective of the
study was to determine patterns of mRNA expression
for the IGF system within the previously gravid (PG)
and previously non-gravid (PNG) uterine horns during
the early postpartum period. Samples were obtained at
approximately 2 weeks after calving as we hypothesiseddocrinology 34 (2008) 391–402
that this represents a time by which a delay in the normal
recovery process may predispose cows to the subsequent
development of endometritis.
2. Materials and methods
2.1. Animals and tissue samples
All procedures were carried out under license in
accordance with the European Community Directive,
86-609-EC. Uteri were collected from 12 multiparous
Holstein-Friesian dairy cows (mean parity 4.7) following
slaughter at day 14 ± 0.4 postpartum. The diameters of
both horns were measured approximately 5 cm anterior
to the bifurcation of the uterus. Samples of inter-
caruncular and caruncular tissue were dissected from the
previously gravid and non-gravid uterine horns approx-
imately 1 cm anterior to the bifurcation of the uterus. A
5 cm square region was harvested, wrapped in aluminium
foil, and frozen in liquid nitrogen-tempered isopentane.
Samples were stored at −80 ◦C until sectioning.
2.2. In situ hybridisation
The in situ hybridisation procedure was performed
as described previously [26]. All chemicals were pur-
chased from Sigma–Aldrich Company Ltd. (Poole,
Dorset, UK) or VWR International Ltd. (Poole, Dorset,
UK) unless otherwise specified. Briefly, sections of
10m were cut from each uterine tissue sample and
thaw-mounted onto SuperFrost® Plus or POLYSINETM
microscope slides, fixed in 4% (w/v) paraformalde-
hyde in 0.01 M PBS, washed in PBS, and sequentially
dehydrated in 70% and 95% ethanol. The oligonu-
cleotide probes for the IGF system were end-labelled
with [35S]dATP (Amersham Biosciences UK Ltd.,
Buckinghamshire, England) using terminal deoxynu-
cleotidyl transferase (Promega UK Ltd., Southampton,
England). Tissue sections were subsequently treated
with 100 000 cpm (100l)−1 hybridisation buffer and
hybridised overnight at either 42, 45, or 52 ◦C (Table 1).
Following incubation, slides were washed in a solution
of 1 × SSC, 2 g l−1 sodium thiosulphate at room tem-
perature for 30 min followed by fresh 1 × SSC, 2 g l−1
sodium thiosulphate at 60 ◦C for 60 min. Slides were
then rinsed in solutions of 1 × SSC, 0.1 × SSC, 75%
ethanol and 95% ethanol and air-dried before expo-
sure to -max hyperfilm (Kodak BioMax MR Film)
for either 4 or 5 days. All uterine sections treated with
a particular probe were hybridized in the same batch.
Sense probes, which were identical in sequence to the
respective mRNA targets, were always included as neg-
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ative controls and any signal from these was regarded as
non-specific. Each batch also contained an appropriate
positive control tissue, based on previous studies. These
were cross-sections of uterus from an estrous ewe for
IGF-I and the type 1 IGF receptor [20], IGFBP-1 [27] and
IGFBP-6 [28]; ovine placentome for IGF-II and IGFBPs-
2, -3 and -4 [29] and ovine intercotyledonary tissue for
IGFBP-5 [30].
2.3. Photographic emulsions
To aid cellular localisation of hybridised probes,
slides previously subject to autoradiography were
coated with photographic emulsion LM1 (Amersham
Biosciences UK Ltd., Buckinghamshire, England)
according to the manufacturer’s instructions and stored
for 28, 30 or 42 days at 4 ◦C in the dark (Table 1). The
slides were developed in 20% phenisol (ILFORD Imag-
ing UK Ltd., Cheshire, England) fixed in 1.9 M sodium
thiosulphate and counterstained with haematoxylin and
eosin. All other slides were also stained with haema-
toxylin and eosin to aid identification of tissue region.
2.4. Optical density measurements
Readings were obtained from at least two sections
per tissue for each of the antisense (AS) and sense
(S) probes. Autoradiographs were scanned into a com-
puter and optical density (OD) measurements were
recorded from digital images. The relative expression
of mRNA for components of the uterine IGF system
was quantified from the autoradiographs using the pub-
lic domain NIH ImageJ program (available through the
NIH website—http://www.nih.gov), which calculated
the average optical density (OD) over the selected area
of film based on a linear grey scale of 0.01–2.71. The
following tissue layers were each assessed separately:
luminal epithelium, sub-epithelial stroma (a layer of
dense connective tissue underlying the luminal epithe-
lium), caruncular stroma (the dense connective tissue
forming the caruncles), deep endometrial stroma (loose
connective tissue between the sub-epithelial stroma and
the myometrium) and myometrium. The latter two tis-
sue types were only present in samples collected from
the inter-caruncular region. Each tissue type was mea-
sured separately on each section. The background OD,
from a blank area of film, was also measured and
subtracted from both AS and S OD measurements.
Finally the S values were subtracted from AS values
to give an average OD value for specific hybridisation
[31]. The detection limit was taken as an OD value
of 0.01.
imal Endocrinology 34 (2008) 391–402
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2.5. Statistical analysis
Statistical analyses were performed using Statistical
Package for the Social Sciences (SPSS for Windows,
V13.0). Data for uterine diameter measurements at the
time of tissue collection were analysed using Student’s
t-test. OD measurements were obtained from four sam-
ples per cow, taken from each of the caruncular and
inter-caruncular regions of the previously gravid and
non-gravid horns. The effects of uterine horn and tissue
region on the level of mRNA expression for each probe
were analysed by general linear model analysis. Cow was
entered as a random effect. For this purpose, data from
uteri in which a particular probe showed no detectable
specific hybridisation (OD of <0.01) were given an OD
of 0.01, which equated to the lower limit of detection.
Results were considered statistically significant when
P < 0.05.
3. Results
At the time of tissue collection, the diameter of the
previously gravid uterine horn was larger than that of
the previously non-gravid uterine horn (56 ± 6.9 and
31 ± 3.1 mm, respectively, mean ± S.E.M., P = 0.005).
The spatial distribution of mRNA encoding components
of the uterine IGF system is shown in Figs. 1 and 2. The
concentrations of mRNA in OD units are summarised in
Table 2 according to uterine horn and tissue region and
their two-way interactions are illustrated in Figs. 3 and 4.
The method used provided a semi quantitative measure
of the intensity of mRNA expression in specific cell
types.
3.1. Expression of the IGFs and IGF type 1 receptor
IGF-I mRNA was localized to the sub-epithelial
stroma (SES) of inter-caruncular and caruncular
endometrium in both uterine horns (Figs. 1(A) and 2A).
Both IGF-II and IGF-1R expression was detected in the
deep endometrial stroma (DES), the caruncular stroma
(not shown) and myometrium (Figs. 1(C), (E) and 2C, E).
Overall expression of IGF-I mRNA was higher in
the inter-caruncular than caruncular SES (P = 0.001,
Table 2). There was a significant horn × region inter-
action (P = 0.032), with lower levels of IGF-I transcript
in the inter-caruncular SES of the PG compared with the
PNG horn (Fig. 3(A)). IGF-II expression was higher in
the DES than in the caruncular stroma and myometrium
(P≤ 0.001, Table 2). When data from tissue regions
were pooled the concentration of IGF-II mRNA did
not vary between the PNG and PG horns, but there Ta
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Fig. 1. Expression of mRNA for the IGF system in the involuting uterus of postpartum dairy cows. Autoradiographic localisation of mRNA for:
(A and B) IGF-I, (C and D) IGF-II, (E and F) IGF-1R, (G and H) IGFBP-2, (I and J) IGFBP-3, (K and L) IGFBP-4, (M and N) IGFBP-5, and (O
and P) IGFBP-6. Examples of antisense (A, C, E, G, I, K, M and O) and sense (B, D, F, H, J, L, N and P) probes are illustrated. IGF-I mRNA was
expressed in the sub-epithelial stroma (SES); IGF-II and IGF-1R mRNA was detected in the deep endometrial stroma (DES), caruncular stroma
(not shown) and myometrium (MYO). IGFBP-2 mRNA was detected in the SES, DES and CS. The expression of IGFBP-3 mRNA was confined
t RNA w
a expres
w
E
w
m
P
h
c
l
P
a
eo the luminal epithelium (LE). IGFBP-4, IGFBP-5 and IGFBP-6 m
dditionally detected in DES. IGFBP-4 and IGFBP-5 mRNA was also
as a significant horn × region interaction (P≤ 0.001).
xpression of IGF-II in the DES and caruncular stroma
as lower in the PG than PNG horn, whereas within
yometrium expression was higher in the PG than
NG horn (Fig. 3(B)). For the IGF-1R, expression was
ighest in myometrium and similar between DES and
aruncular stroma (Table 2 and Fig. 3(C)). Overall, the
evel of IGF-1R transcript was higher (P = 0.030) in the
NG than PG horn (Table 2). The horn × region inter-
ction was not significant for uterine IGF-1R mRNA
xpression.as localised to the SES and CS with IGFBP-4 and IGFBP-6 mRNA
sed in the MYO. Scale bars = 5 mm.
3.2. Expression of IGFBPs
IGFBP-1 mRNA could not be detected in any
uteri examined, despite expression being observed
in the ovine estrous uterus which was used as
positive control tissue (data not shown). IGFBP-2,
IGFBP-4 and IGFBP-6 mRNAs were all localised
to the SES of inter-caruncular and caruncular uter-
ine tissue, and in the DES and caruncular stroma
(Figs. 1(G), (K), (O) and 2G, K, O). IGFBP-4 mRNA
was additionally expressed in myometrium. In contrast,
396 S. Llewellyn et al. / Domestic Animal Endocrinology 34 (2008) 391–402
Fig. 2. Photographs of uterine sections coated with photographic emulsion and counterstained with haematoxylin and eosin to determine the cellular
F) IGF-
, C, E,
; LE, lulocalisation of mRNA for (A and B) IGF-I, (C and D) IGF-II, (E and
and N) IGFBP-5, and (O and P) IGFBP-6. Examples of antisense (A
illustrated. SES, sub-epithelial stroma; DES, deep endometrial stroma
IGFBP-3 mRNA expression was only detected in the
luminal epithelium (LE) of both inter-caruncular and
caruncular samples (Figs. 1(I) and 2I). IGFBP-5 mRNA
was found in myometrium, inter-caruncular and carun-
cular SES and caruncular stroma (Figs. 1(M) and 2M).IGFBP-2 mRNA expression in inter-caruncular and
caruncular SES was higher than in DES and caruncu-
lar stroma (P≤ 0.001, Table 2). There was no main
effect of horn, but there was a horn × region interaction1R, (G and H) IGFBP-2, (I and J) IGFBP-3, (K and L) IGFBP-4, (M
G, I, K, M and O) and sense (B, D, F, H, J, L, N and P) probes are
minal epithelium; MYO, myometrium. Scale bars = 100m.
(P = 0.034). Within caruncular stroma only, the concen-
tration of IGFBP-2 mRNA was higher in the PG than the
PNG uterine horn (Fig. 4(A)).
For IGFBP-3 mRNA the main effects of uterine
horn and tissue region were not significant but there
was an interaction (P≤ 0.001). Expression in the inter-
caruncular LE was higher in the PNG than PG horn,
whereas in the caruncular LE expression was higher in
the PG uterine horn (Fig. 4(B)).
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Fig. 3. Expression of (A) IGF-I, (B) IGF-II, and (C) IGF-1R mRNA in different tissue regions and uterine horns of the involuting bovine uterus.
iLE, inter-caruncular luminal epithelium; cLE caruncular luminal epithelium; iSES, inter-caruncular sub-epithelial stroma; cSES, caruncular sub-
epithelial stroma; DES, deep endometrial stroma; CS, caruncular stroma; MYO, myometrium; PNG, previously non-gravid horn; PG, previously
gravid horn. Values are mean ± S.E.M. of data from 12 cows. Differences due to tissue region are indicated with different superscript letters
(P≤ 0.001). Differences due to horn for a particular tissue region are indicated by *P < 0.05, ***P≤ 0.001.
Fig. 4. Expression of (A) IGFBP-2, (B) IGFBP-3, (C) IGFBP-4, (D) IGFBP-5, and (E) IGFBP-6 mRNA in different tissue regions and uterine horns
of the involuting bovine uterus. iLE, inter-caruncular luminal epithelium; cLE caruncular luminal epithelium; iSES, inter-caruncular sub-epithelial
stroma; cSES, caruncular sub-epithelial stroma; DES, deep endometrial stroma; CS, caruncular stroma; MYO, myometrium; PNG, previously non-
gravid horn; PG, previously gravid horn. Values are mean ± S.E.M. of data from 12 cows. Differences due to tissue region are indicated with different
superscript letters (P≤ 0.001). Differences due to horn for a particular tissue region are indicated by *P < 0.05, **P < 0.010, and ***P≤ 0.001.
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Expression levels of IGFBP-4 mRNA varied between
tissue regions, with higher expression in the carun-
cular than inter-caruncular SES, lowest expression in
myometrium, and intermediate signal intensity in the
DES and caruncular stroma (Table 2). There was no
difference in transcript levels between the PNG and
PG uterine horns when regional data were combined
(Table 2). Levels of IGFBP-4 mRNA expression were,
however, affected by an interaction between uterine horn
and tissue region (P = 0.024): within DES expression was
lower in the PG than PNG uterine horn (Fig. 4(C)).
Expression of IGFBP-5 mRNA was highest in
myometrium, intermediate in the inter-caruncular and
caruncular SES and lowest in caruncular stroma
(P≤ 0.001, Table 2). When regional expression data
were pooled, the PNG uterine horn expressed higher
concentrations of IGFBP-5 mRNA than the PG horn
(P≤ 0.001, Table 2). There was also a significant effect
of the interaction between uterine horn and tissue region
(P≤ 0.001). Expression in both the inter-caruncular SES
and the caruncular stroma was lower in the PG than PNG
uterine horn whereas for the caruncular SES the reverse
was true (Fig. 4(D)).
IGFBP-6 mRNA was expressed at higher concentra-
tions in the inter-caruncular and caruncular SES than in
DES and caruncular stroma (P≤ 0.001, Table 2). Tran-
script levels were higher (P≤ 0.001) in the PNG than
PG uterine horn when regional expression data were
pooled (Table 2). The interaction between uterine horn
and tissue region was significant (P = 0.045). Expression
in each of the inter-caruncular SES, caruncular SES,
DES and caruncular stroma was lower in the PG than
PNG horn (Fig. 4(E)).
4. Discussion
The rate of uterine involution is an important factor
influencing the subsequent fertility of dairy cows [24].
In this study we have investigated for the first time a
possible role for the IGF family of proteins in this event
in lactating dairy cows. The timing of tissue collection
at approximately day 14 postpartum occurred when the
PG uterine horn in our group of multiparous cows was
larger than the PNG horn. At this stage caruncular tissue
is expected to have undergone degeneration and slough-
ing, but not to have completed re-epithelialisation [2].
In contrast, the inter-caruncular area does not lose its
epithelial layer [32] and recovers from pregnancy more
quickly [2]. The ongoing process of uterine involution at
the time of tissue collection was thus expected to involve
tissue regeneration alongside size recovery. An adequate
recovery process may be crucial in preventing the uterus,docrinology 34 (2008) 391–402
which is heavily contaminated with bacteria following
calving [1], from developing endometritis. Samples were
analysed using in situhybridisation. Whilst this approach
is considered only semi-quantitative, we have found
the technique described here to be highly repeatable.
Furthermore, it enables measurement of mRNA concen-
trations in individual cellular types. This is not feasible
in a complex organ such as the uterus using alternative
techniques such as RT-PCR, as it is not readily possible
to separate different populations of epithelial and stromal
cells for RNA extraction.
IGF-I mRNA was localised to the SES, confirming
earlier observations in the cow [33] and sheep [20,34].
Normal wound healing involves a sequence of inflamma-
tion, proliferation, and maturation or remodelling [12]
and local IGF-I production increases as wound healing
progresses [35]. Since IGF-I increases during the late
proliferative phase of the human menstrual cycle [36],
and is known to stimulate cell proliferation and collagen
synthesis during tissue regeneration [14,35], we propose
that IGF-I produced by SES may act in an autocrine
and/or paracrine manner to stimulate the proliferation
of uterine stroma and epithelium [37,38] during uterine
involution.
In early pregnancy the bovine endometrium synthe-
sises IGF-II primarily within caruncular stroma [33]. The
present study localised IGF-II mRNA at similar concen-
trations in both the caruncular stroma and myometrium.
The strongest expression of IGF-II mRNA was, how-
ever, in the DES. Similar results were found in human
endometrium [36]. IGF-1R was similarly localised to
the DES, caruncular stroma and myometrium, confirm-
ing earlier observations in the bovine uterus [33]. Since
the effects of IGF-II are probably mediated by the IGF-
1R (for a review see [39]), the co-localisation of IGF-II
and IGF-1R transcripts supports a local action for IGF-II
in uterine repair and regeneration within both endome-
trial and caruncular stroma [16,21]. Stromal IGF-II may
also act in a paracrine manner to stimulate epithelial
cell proliferation [22]. The interaction between IGFs and
their receptors in muscle growth and regeneration has
been comprehensively reviewed by Florini et al. [40].
In myometrium, IGF-II may stimulate muscle growth
and regeneration [40], and potentially increases muscle
strength [41]. These actions would support myometrial
contractions that return the uterus to its non-pregnant
size, shape and tone [5]. Since the PG horn has to contract
from a larger size at parturition, the higher concentration
of IGF-II in the PG myometrium supports the proposal
that IGF-II assists postpartum uterine size recovery. In
rat myometrium the IGF-1R is up-regulated in the early
postpartum period [42].
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This study failed to detect IGFBP-1 mRNA in any
ostpartum uteri. During the estrous cycle IGFBP-1
xpression is low at estrous and relatively higher during
he luteal phase [33] concurrent with progesterone pro-
uction. Since the cows in this study had yet to establish
vulatory cycles, then the uterus would not have been
ecently exposed to progesterone stimulation [43]. In
uminants IGFBP-1 appears to be involved in pregnancy
ecognition [33,44] rather than, as this study shows, post-
artum uterine events.
In agreement with previous studies [33,44], the
xpression of uterine IGFBP-2 mRNA was localised to
he SES and at relatively lower levels in the DES and
aruncular stroma. In the cyclic cow IGFBP-2 mRNA
evels increased during the luteal phase, concomitant
ith the highest levels of plasma progesterone [19].
ther studies have shown that human endometrial cells
onstitutively synthesise and secrete IGFBP-2 in vitro
45] and in response to estradiol [46]. In the bovine
ammary gland [47], IGF-I may stimulate IGFBP-2
xpression and protein secretion, whereas in fetal vis-
eral glomerular epithelial cells isolated from human
idneys IGFBP-2 production was stimulated by IGF-
I [48]. The exact mechanisms regulating postpartum
terine IGFBP-2 mRNA expression thus requires fur-
her investigation. IGFBP-2 is presumably modulating
terine involution indirectly by regulating the bioavail-
bility of IGF-I and IGF-II and the interaction of
hese ligands with their receptors [39]. The precise
ction of IGFBP-2 also remains uncertain. Both stimu-
atory [22] and inhibitory [48] actions of IGFBP-2 on
GF-stimulated epithelial cell proliferation have been
uggested. Alternatively or additionally, IGFBP-2 could
odulate uterine cell growth directly [22].
In contrast to all the other binding proteins investi-
ated, the expression of IGFBP-3 mRNA was confined
o the luminal epithelium, again agreeing with earlier
ork in the cyclic animal [33]. Epithelial IGFBP-3 may
egulate local IGF bioavailability [39] or transport IGFs
cross this cell layer [49,50] for secretion into the uter-
ne lumen. Removing excess IGF from the endometrium
ould prevent the IGF-1R from being down-regulated
51]. Alternatively, since IGFBP-3 associates with cell
urfaces, then it may store IGFs [52] in the uterus and
urther promote IGF-stimulated tissue repair [37,39] as
roposed for other physiological systems [53].
IGFBP-4 mRNA was detected in multiple uterine
issue compartments. The localisation in SES and carun-
ular stroma has also been found in the pregnant ewe
54] and synthesis in the DES and myometrium agrees
ith studies in the human and pregnant bovine uterus
44,55]. IGFBP-4 is generally considered inhibitory todocrinology 34 (2008) 391–402 399
IGF actions [56]. IGFBP-4 does not appear to bind to
the cell surface or extracellular matrix, but can cross the
endothelium [39], indicating that IGFBP-4 may clear
endometrial IGFs.
IGFBP-5 mRNA was localised to caruncular stroma
and myometrium, in agreement with previous studies
in the cow [33] and sheep [34], and transcript was also
detected in the SES. With a lack of detectable IGFBP-2,
IGFBP-3, and IGFBP-6 mRNA alongside relatively low
levels of IGFBP-4 mRNA in the myometrium, the abun-
dance of IGFBP-5 in this tissue suggests this binding
protein as the primary regulator of local IGF bioavail-
ability [57]. In the rat myometrium, IGFBP-5 mRNA
is significantly up-regulated after parturition, which is
suggested to support tissue remodelling during involu-
tion [42]. It is also possible that within the myometrium,
IGFBP-5 is directly stimulating muscle cell survival dur-
ing myogenesis [57,58]. In stromal fibroblasts, IGFBP-5
can adhere to the extracellular matrix, which decreases
its affinity for IGF and can potentiate IGF-stimulated
DNA synthesis [39,59]. Furthermore, IGFBP-5 may
stimulate local tissue growth independently of IGF
[39,59].
IGFBP-6 was localised to SES and at lower levels in
DES and caruncular stroma, similar to the non-pregnant
ovine uterus [28]. This expression pattern parallels
that of IGFBP-2 mRNA and may suggest these two
binding proteins are co-regulated [60]. IGFBP-6 has
a markedly higher affinity for IGF-II [61] and so the
major function of IGFBP-6 is probably to regulate IGF-
II actions [62,63]. Furthermore, IGFBP-6 is generally
considered to inhibit the effects of IGF-II, including
cell proliferation and differentiation [59]. The impor-
tance of controlling uterine IGF bioactivity has been
demonstrated in the human uterus where low levels of
IGFBP-6 and higher levels of IGF-II are associated with
uterine leiomyomas (fibroids), compared with normal
endometrium [64].
Many members of the IGF family showed differential
expression between the two uterine horns. Expression of
IGF-I, the IGF-1R and IGFBP-6 was at an overall lower
level in the previously gravid horn whereas IGFBP-4
mRNA expression was lower in the DES only. IGF-
II, IGFBP-3 and IGFBP-5 expression showed horn by
region interactions, with mRNA concentrations reduced
for some regions but increased for others. These dif-
ferences may reflect the temporal misalignment of the
horns in their rate of tissue remodelling, with the PG
horn lagging behind the PNG horn by up to 15 days [7].
In conclusion, the IGF system is significant to uter-
ine function and the synthesis of these growth factors
in the postpartum uterus indicates a role in uterine
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involution. This study has shown that in the postpar-
tum bovine uterus IGF-I synthesis was localised to
sub-epithelial stroma, whilst maximum concentrations
of IGF-II and IGF-1R mRNA were in the endome-
trial stroma and myometrium, respectively. The uterine
tissue compartments expressed different profiles of IGF-
binding proteins, indicating that IGF bioavailability and
bioactivity is differentially regulated throughout the
regenerating endometrium. IGFs are presumably sup-
porting the tissue repair that follows parturition, similar
to that of normal wound healing [12]. We propose that
myometrial IGF-II synthesis stimulates tissue recovery
in an autocrine manner, which may assist the uterus
returning to its non-pregnant shape and size. Although
IGFs may be key physiological mediators of endometrial
repair, other growth factors and cytokines are undoubt-
edly also important in this process [11,65].
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